Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference
(Thomson Reuters ONE) -
GAITHERSBURG, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced that Stanley C. Erck, President and CEO, will present
at the 27(th) Annual Piper Jaffray Healthcare Conference.
Conference details are as follows:
Date: Tuesday, December 1, 2015
Time: 2:00 p.m. U.S. Eastern Time
Location: New York Palace Hotel, New York City
Live webcast: http://edge.media-server.com/m/p/ui3ne8dn
The webcast and a replay of the presentation will also be accessible under the
"Investors/Events" section of the Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the Company's website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir(at)novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
212-845-4271
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1969132]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Engagement Labs: 2015 Q3 Revenue of $1.7 Million Up from $839k in Q2 resulting in a 108% Sequential Quarterly Growth
Datum: 24.11.2015 - 22:05 Uhr
Sprache: Deutsch
News-ID 435640
Anzahl Zeichen: 2310
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 160 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
